Model Number LSMU0800826 |
Device Problem
Device Dislodged or Dislocated (2923)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 06/03/2019 |
Event Type
malfunction
|
Manufacturer Narrative
|
As the lot number for the device was provided, a manufacturing review will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.The catalog number identified in section has not been cleared in the u.S.But, it is similar to the lifestream balloon expandable vascular covered stent products that are cleared in the us.The 510 k number and pro code for the lifestream balloon expandable vascular covered stent products are identified.(expiry date 05/2020).The information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
Event Description
|
It was reported that during treatment of the mesenteric artery via calcified and tortuous right common femoral access, the stent allegedly dislodged from the delivery system while advancing to the lesion; as a result, the stent graft was snared and removed from the body.It was further reported that no additional stents were used to complete the procedure due to the degree of calcification in the lesion.There was no reported patient injury.
|
|
Manufacturer Narrative
|
H10: manufacturing review: a manufacturing review was not required as this was the first complaint reported for this lot number.Based on the severity and lot quantity the number of events is within the acceptable quality levels.Investigation review: the investigation is confirmed for the reported stent dislodgment issue.The stent was returned separate to the device and had not been expanded.There was extensive damage to the stent likely caused when snaring it during its- retrieval from the patient.The definitive root cause for the reported stent dislodgment issue could not be determined based upon available information.Labeling review: the event description states that the lifestream device was being used in the mesenteric artery.This is off label use of the device.The lifestream stent is intended only in the treatment of atherosclerotic lesions in the common and external iliac arteries per the instructions for use.H10: g3, g4, d4 (expiry date 05/2020).H11:d10, h3, h6(methods, results, conclusion).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
Event Description
|
It was reported that during treatment of the mesenteric artery via calcified and tortuous right common femoral access, the stent allegedly dislodged from the delivery system while advancing to the lesion; as a result, the stent graft was snared and removed from the body.It was further reported that no additional stents were used to complete the procedure due to the degree of calcification in the lesion.There was no reported patient injury.
|
|
Search Alerts/Recalls
|
|